Epidarex Capital

Investment thesis

Transatlantic life-sciences specialist that creates and invests in early-stage, high-growth therapeutics and medical-device companies in under-ventured research hubs, spanning oncology, cardiometabolic, autoimmune and neurological conditions. Closed £100m+ Fund IV.

Notable portfolio

Sector focus